Literature DB >> 14212847

LYSOLECITHIN AND THE ACTION OF COMPLEMENT.

H FISCHER.   

Abstract

Entities:  

Keywords:  ANTIGEN-ANTIBODY REACTIONS; CAPILLARY PERMEABILITY; CARCINOMA, EHRLICH TUMOR; CELL MEMBRANE PERMEABILITY; CHROMATOGRAPHY; COMPLEMENT; EXPERIMENTAL LAB STUDY; LYSOLECITHIN; METABOLISM; PHAGOCYTOSIS

Mesh：

Substances：

Year:  1964        PMID： 14212847     DOI： 10.1111/j.1749-6632.1964.tb52568.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  7 in total

1.  Ether lipids in oncology-welcoming address.

Authors:  O Westphal
Journal:  Lipids       Date:  1987-11       Impact factor: 1.880

2.  Reactive haemolysis--a distinctive form of red cell lysis.

Authors:  R A Thompson; D S Rowe
Journal:  Immunology       Date:  1968-05       Impact factor: 7.397

3.  A study of the mechanisms of attachment of allergised lymphocytes to BP8 ascites tumour cells.

Authors:  P J Lee; D B Cater
Journal:  Br J Exp Pathol       Date:  1969-12

Review 4.  The membrane attack complex.

Authors:  H J Müller-Eberhard
Journal:  Springer Semin Immunopathol       Date:  1984

5.  Changes in lipid pattern of HeLa cells exposed to immunoglobulin G and complement.

Authors:  F Güttler; J Clausen
Journal:  Biochem J       Date:  1969-12       Impact factor: 3.857

6.  Inflammatory changes in tumour vessels after systemic 5-hydroxytryptamine, bradykinin, kallikrein, or lysolecithin.

Authors:  D B Cater; C R Taylor
Journal:  Br J Cancer       Date:  1966-09       Impact factor: 7.640

Review 7.  The Potential of Novel Lipid Agents for the Treatment of Chemotherapy-Resistant Human Epithelial Ovarian Cancer.

Authors:  Mark W Nachtigal; Alon D Altman; Rajat Arora; Frank Schweizer; Gilbert Arthur
Journal:  Cancers (Basel)       Date:  2022-07-07       Impact factor: 6.575
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.